Condition 1: Dental implant. Condition 2: Edentuous ridge atrophy. K00-K14Presence of tooth-root and mandibular implants Atrophy of edentulous alveolar ridge
Conditions
Interventions
Intervention 1: Intervention group: Patients who meet inclusion criteria, after signing an informed consent enter the study.
Surgery for implant placement: Patients rinse their mouth with chlorhexidin
test group will receive Aesthetica tissue-level implants. The length of implant chosen is 6 or 8 millimeters, depending on the available bone. Drilling and placing implant at desired level relative to
Treatment - Surgery
Treatment - Drugs
Intervention group: Patients who meet inclusion criteria, after signing an informed consent enter the study.
Surgery for implant placement: Patients rinse their mouth with chlorhexidine 2.2% mouthrin
Control group: Patients who meet inclusion criteria, after signing an informed consent enter the study.
Surgery for implant placement: Patients rinse their mouth with chlorhexidine 2.2% mouthrinse. L
control group will receive Natea bone-level implants. The length of implant chosen is 6 or 8 millimeters, depending on the available bone. Drilling and placing implant at desired level relative to bon
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: Edentulous area of at least one tooth missed in the posterior sextant of maxilla; which is considered to be treated with implant supported fixed prosthesis; available bone height of at least 6 mm and less than 10 mm below the maxillary sinus in the area planned for implant insertion, as observed in CBCT radiograph; available bone width of at least 6 mm in the area planned for implant insertion as observed in CBCT radiograph; sinus augmentation not planned, because of medical reasons or patient's unwillingness; and patient's willing for cooperation with the study. Exclusion criteria: Active periodontal disease (Probing pocket depth >=4 mm with bleeding on probing); full mouth plaque score >20% at time of implant placement; full mouth bleeding score >20% at time of implant placement; smoking >10 cigarettes/day; systemic disease or conditions which influence bone metabolism; and bruxism or clenching.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Marginal bone level changes. Timepoint: At implant placement, prosthesis delivery and 6 months later. Method of measurement: a standardized radiograph is taken For evaluation of marginal bone level, CBCT viewer software is used for assessing the radiographs. the distance between bone to implant contact and platform of each implant, at mesial and distal of implants were calculated at each intervals. | — |
Secondary
| Measure | Time frame |
|---|---|
| Probing depth. Timepoint: At prosthesis delivery and 6 months later. Method of measurement: O’ Michigan, Williams marking probe.;Bleeding on probing. Timepoint: At prosthesis delivery and 6 months later. Method of measurement: Bleeding on probing with O’ Michigan, Williams marking, which may happen till 30 seconds later.;Implant survival rate. Timepoint: At prosthesis delivery and 6 months later. Method of measurement: Percentage of remained implants in oral cavity at the end of study. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMina Taheri
Department of periodontics, Tehran University of Medical Sciences, School of Dentistry
Outcome results
None listed